62
Views
13
CrossRef citations to date
0
Altmetric
Original Research

MicroRNA-384 inhibits proliferation migration and invasion of glioma by targeting at CDC42

, , , , &
Pages 4075-4085 | Published online: 16 Jul 2018

References

  • DeWittJCJordanJTFroschMPCost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendationsNeuro Oncol201719121640165029016871
  • RicardDIdbaihADucrayFLahutteMHoang-XuanKDelattreJYPrimary brain tumours in adultsLancet201237998301984199622510398
  • HataALiebermanJDysregulation of microRNA biogenesis and gene silencing in cancerSci Signal20158368re325783160
  • KimMKasinskiALSlackFJMicroRNA therapeutics in preclinical cancer modelsLancet Oncol201112431932121463831
  • ZhengHBZhengXGLiuBPmiRNA-101 inhibits ovarian cancer cells proliferation and invasion by down-regulating expression of SOCS-2Int J Clin Exp Med20158112026320270 eCollection 201526884939
  • KouriFMRitnerCSteghAHmiRNA-182 and the regulation of the glioblastoma phenotype – toward miRNA-based precision therapeuticsCell Cycle201514243794380026506113
  • WuFLiJGuoNWangXHLiaoYQMiRNA-27a promotes the proliferation and invasion of human gastric cancer MGC803 cells by targeting SFRP1 via Wnt/β-catenin signaling pathwayAm J Cancer Res201773405416 eCollection 201728401000
  • FuZLiGLiZEndogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer cellsCell Death Discov201731700428580169
  • WangGPanJZhangLWeiYWangCLong non-coding RNA CRNDE sponges miR-384 to promote proliferation and metastasis of pancreatic cancer cells through upregulating IRS1Cell Prolif2017506
  • SunHHeLMaLLncRNA CRNDE promotes cell proliferation, invasion and migration by competitively binding miR-384 in papillary thyroid cancerOncotarget201786611055211056529299168
  • BaiPSXiaNSunHKongYPleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinomaJ Cell Mol Med201721113023304328557334
  • WangYXChenYRLiuSSMiR-384 inhibits human colorectal cancer metastasis by targeting KRAS and CDC42Oncotarget2016751848268483827769041
  • MezzacappaCKomiyaYHabasRActivation and function of small GTPases Rho, Rac, and Cdc42 during gastrulationMethods Mol Biol201283911913122218897
  • SinhaSYangWCellular signaling for activation of Rho GTPase Cdc42Cell Signal200820111927193418558478
  • FidykNWangJBCerioneRAInfluencing cellular transformation by modulating the rates of GTP hydrolysis by Cdc42Biochemistry200645257750776216784226
  • VanniCOttavianoCGuoFConstitutively active Cdc42 mutant confers growth disadvantage in cell transformationCell Cycle20054111675168216294011
  • LinRBagrodiaSCerioneRManorDA novel Cdc42Hs mutant induces cellular transformationCurr Biol19977107947979368762
  • WangJBEricksonJWFujiRTargeting mitochondrial glutaminase activity inhibits oncogenic transformationCancer Cell201018320721920832749
  • FortinSPEnnisMJSchumacherCACdc42 and the guanine nucleotide exchange factors Ect2 and trio mediate Fn14-induced migration and invasion of glioblastoma cellsMol Cancer Res201210795896822571869
  • OkuraHGolbournBJShahzadUA role for activated Cdc42 in glio-blastoma multiforme invasionOncotarget2016735569585697527486972
  • ReyesSBNarayananASLeeHSαvβ8 integrin interacts with RhoGDI1 to regulate Rac1 and Cdc42 activation and drive glioblastoma cell invasionMol Biol Cell201324447448223283986
  • TangHWangZLiuXLRRC4 inhibits glioma cell growth and invasion through a miR-185-dependent pathwayCurr Cancer Drug Targets20121281032104222834685
  • DeWittJCMockALouisDNThe 2016 WHO classification of central nervous system tumors: what neurologists need to knowCurr Opin Neurol201730664364928901970
  • LivakKJSchmittgenTDAnalysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) MethodMethods200125440240811846609
  • ChenCHStattSChiuCLTargeting myristoylated alaninerich C kinase substrate phosphorylation site domain in lung cancer. Mechanisms and therapeutic implicationsAm J Respir Crit Care Med2014190101127113825318062
  • ChengZLiuFWangGLiYZhangHLiFmiR-133 is a key negative regulator of CDC42-PAK pathway in gastric cancerCell Signal201426122667267325152372
  • FuMGLiSYuTTDifferential expression of miR-195 in esophageal squamous cell carcinoma and miR-195 expression inhibits tumor cell proliferation and invasion by targeting of Cdc42FEBS Lett2013587213471347924025765
  • NandySBOrozcoALopez-ValdezRGlucose insult elicits hyperactivation of cancer stem cells through miR-424-cdc42-prdm14 signalling axisBr J Cancer2017117111665167529024936
  • ShiCRenLSunCmiR-29a/b/c function as invasion suppressors for gliomas by targeting CDC42 and predict the prognosis of patientsBr J Cancer201711771036104728787434
  • van der SandenBRatelDBergerFWionDGlioma recurrence following surgery: peritumoral or perilesional?Front Neurol201675227065944
  • A MirzaFShamimMSExtent of resection and timing of surgery in adult low grade gliomaJ Pak Med Assoc201767695996128585606